MedDataX Logo

Energy Metabolism Profiles Over Weight-loss and Eating Responses

NCT ID: NCT05785221

Last Updated: 2025-12-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

117 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-02

Study Completion Date

2026-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an exploratory controlled before-after study, which involves 112 participants, of whom 28 are with normal weight and 84 are overweight or obese. Twelve weeks of personalized nutritional and lifestyle weight reduction intervention will be conducted in the overweight or obese participants. The objectives of this study are 1) to characterize energy metabolic responses under acute nutritional challenge and acute exercise challenge, 2) to investigate whether weight-loss intervention can improve metabolic health, and 3) to explore the potential impact factors on heterogenous postprandial and post-intervention energy metabolism.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objectives of this study are 1) to characterize energy metabolic responses under acute nutritional challenge and acute exercise challenge, 2) to investigate whether weight-loss intervention can improve metabolic health, and 3) to explore the potential impact factors on heterogenous postprandial and post-intervention energy metabolism.

In this study, 84 overweight or obese participants (BMI ≥ 24 kg/m2) and 28 normal weight participants (18.5 ≤ BMI\<24 kg/m2) will be recruited and receive 12-week personalized weight reduction or weight maintenance nutritional and lifestyle interventions. Before and after the 12-week interventions, metabolic homeostasis will be used to characterize metabolic health and to be determined using comprehensive measurements of dynamic changes in postprandial metabolic responses (including energy metabolism, multiple clinical biomarkers, metabolomic signatures, gut microbiota, genetic signatures etc.) after the standardized mixed-nutrient dietary challenges (75 g glucose, 60 g fat and 20 g protein) in whole room indirect calorimeter under both resting and exercise conditions. In addition, data from dietary intake, anthropometric measurements, body composition, psychosocial measures, behavior questionnaires and 14-day continuous glucose monitoring will also be collected to characterize metabolic homeostasis. During the interventions, participants will receive personalized dietary advice, behavior guidance and nutritional and lifestyle education by dietitian and physicians. APP-connected wearable devices will be utilized to monitor their dietary intakes, physical activities and sleep conditions, and an application-connected scale will be used to monitor their weight changes during interventions. The study's protocol has been approved by the Ethics Committee of Sir Run Run Shaw Hospital.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Homeostasis Metabolism and Nutrition Disorder Healthy Obesity

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Metabolic homeostasis Healthy Lifestyle intervention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Comparators

They will receive general lifestyle and nutritional education.

Group Type PLACEBO_COMPARATOR

General lifestyle and nutritional education

Intervention Type BEHAVIORAL

Participants will receive general dietary advice, behavior guidance and nutritional and lifestyle education based on dietary guidelines.

Overweight/Obese Group

They will receive personalized nutritional and lifestyle weight reduction intervention including dietary advice, behavior guidance and nutritional and lifestyle education by dietitian and physicians.

Group Type EXPERIMENTAL

Personalized nutritional and lifestyle weight reduction intervention

Intervention Type BEHAVIORAL

Participants will receive personalized dietary advice, behavior guidance and nutritional and lifestyle education by dietitian and physicians. APP-connected wearable devices will be utilized to monitor their dietary intakes, physical activities and sleep conditions and APP-connected scale will be used to monitor their weight changes during interventions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

General lifestyle and nutritional education

Participants will receive general dietary advice, behavior guidance and nutritional and lifestyle education based on dietary guidelines.

Intervention Type BEHAVIORAL

Personalized nutritional and lifestyle weight reduction intervention

Participants will receive personalized dietary advice, behavior guidance and nutritional and lifestyle education by dietitian and physicians. APP-connected wearable devices will be utilized to monitor their dietary intakes, physical activities and sleep conditions and APP-connected scale will be used to monitor their weight changes during interventions.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 20-70 years of age, inclusive
* BMI ≥ 24kg/m2
* Not in other clinical studies currently or in the past three months

Exclusion Criteria

* Fasting glucose \>7.0mmol/L or diagnosed diabetes or taking insulin or other blood glucose-lowering drugs
* Blood pressure \> 160/100 mmHg; diagnosed phase II or III hypertension or cannot decrease SBP under 160mmHg after anti-hypertension drugs
* Fasting blood TG≥ 5.7 mmol/L or fasting LDL-C≥ 4.9 mmol/L or cannot control TG \< 5.7 mmol/L or LDL-C \< 4.9 mmol/L after taking lipid lowering drugs
* Pregnant or lactating
* Attempting to change body weight in the past 3 months
* Use of antibiotic in the preceding 3 months for 3-serial days
* Use of estrogen therapy or hormonal drugs in the preceding 6 months
* Smokers
* History of alcohol abuse or other substance abuse (Alcohol abuse is defined as regular alcohol consumption \> 40 g/day for females or \> 80 g/day for males)
* Severe renal disease or liver disease
* Severe gastrointestinal diseases
* Surgical events preceding 1 year (except appendicitis or hernia surgery)
* Severe cardiovascular or cerebrovascular diseases
* Implantation of heart stent or any device containing metal material
* Cancer or receiving radiotherapy and chemotherapy within 5 years
* Hyperthyroidism or hypothyroidism
* Suffering from AIDS, hepatitis A, hepatitis B and other infectious diseases
* Claustrophobia
* Physical disability
* Any mental disorders or current use of antidepressants
* Cognitive disability
Minimum Eligible Age

20 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sir Run Run Shaw Hospital

OTHER

Sponsor Role collaborator

Chinese Academy of Sciences

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Xu Lin

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xu Lin, PhD

Role: PRINCIPAL_INVESTIGATOR

Institute for Nutritional Sciecnes, CAS; Hangzhou Institute for Advanced Study, UCAS

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences

Hangzhou, Zhejiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HIAS-LIMH-202302

Identifier Type: -

Identifier Source: org_study_id